1.A Clinical Study of Oral Ketoconazole Therapy in Superficial Fungal Diseases: Multicenter Trials.
Do Sik SONG ; Byung In RO ; Chin Yo CHANG ; Hyung Ok KIM ; Choong Rim HAW ; Jae Bok JUN ; Sook Ja SON ; Jai Il YOUN ; Ki Bum MYUNG ; Jae Hong KIM
Korean Journal of Dermatology 1984;22(3):263-272
Ketoconazole is one of the broad-spectrum oral antimycotic agents recently developed from imidazole derivatives. Authors performed multicenter trials to evaluate the therapeutic effect of ketoconazole in superficial fungal diseases. One hundred and eighty-four patients with superficial fungaI diseases were included in this study during 7 months from April to October, 1983 Patiets were treated with oral administration of 200 mg of ketoconazole(Nizoral) once a day for 4 weeks.-countinue-
Administration, Oral
;
Humans
;
Ketoconazole*
2.In vitro study on the influence of excipient on properties of ketoconazole in topical galenic forms
Pharmaceutical Journal 2000;269(12):17-19
In vitro release and fungicidal effect of Ketoconazol from different ointment base at 2% concentration was studied. The rank order of the release pass cellophane membrane was as follow: Emulel > PEG ointments > emulsified ointment > carbopol 934, CMC, HPMC gel. The bank order of the fungicidal effect in vitro was as follow: emulgel and emulsified ointment > hydrophilic ointment
Ketoconazole
;
Imidazoles
;
therapeutics
;
Pharmaceutical Preparations
3.Invitrosensitivity of trichophyton mentagrophytes against oral antifungal agents.
Korean Journal of Dermatology 1992;30(6):769-775
In vitro sensitivity of T. mentagrophytes against antifungal agents was investigated. The 20 strains of T. mentagrophytes were tested. They were 5 strains of granilar form, 5 of powdery form, 5 of persicolor form, and 5 of downy for m. The tested antifungal agents were griseofulvin, ket,oconazole and it,raconazole. The results were as follows : 1. Minimal inhibitory concintration(MIC) of antifungal agents against, T. mentagrophytes : MIC of griseofulvin was 3.13-25 ug/ml, the highest level, that of ketoconazole was 0.05-12 ug/ml, and that of itraconazole was 0.025 6.25 ug/ml, the lowest one. 2. MIC of antifungal agents against T. mentagrophytes strains. MlC of griseofulvin was 12-25 ug/ml on granular form and 3.13-25 ug/ml on the other forms. MIC of ketoconazole was 0.39-12 ug/ml on granular form, 0,05 0.78 ug/ml on powdery form, 0.05 12 ug/ml on persicolor form, and 0.1-12 ug/ml on downy form. MIC of itraconazole was 0.39-6.25 ug/ml on granular form, 0.05-0.39 ug/ml on powdevy form, 0.025-0.05 ug/ml on persicolor form, and 0.05-0.1 ug/ml on downy form. Granular form showed the highest level of MIC among antifungal agents. These findings suggesed that, itraconazole was the most arctive drug against T. mentagrophytes and the pranular form showed the lowest, sensirivity against antifungal agents.
Antifungal Agents*
;
Griseofulvin
;
Itraconazole
;
Ketoconazole
;
Trichophyton*
4.A Case of Neonatal Malassezia Pustulosis Identified as Malassezia Sympodialis.
Hwi Jun KIM ; Mu Hyoung LEE ; Kyu Joong AHN
Korean Journal of Medical Mycology 2001;6(4):229-231
Neonatal Malassezia pustulosis can be defined as pustules on face and neck, age at onset, younger than 1 month, isolation of Malassezia by direct microscopy in pustular material, elimination of other causes of neonatal pustuloses, and response to topical ketoconazole therapy. We report a case of neonatal Malassezia pustulosis in a 20-day-old male. Direct microscopic examination on smears for pustules showed forms of Malassezia yeasts and culture yielded Malassezia sympodialis. The lesions were remarkably improved by topical ketoconazole cream for 14 days.
Humans
;
Ketoconazole
;
Malassezia*
;
Male
;
Microscopy
;
Neck
;
Yeasts
5.Evaluation and comparison in vitro solubility and in vivo absorption of ketoconazole 200mg tablets with nizoral tablets 200mg
Pharmaceutical Journal 2001;298(2):18-22
In this study, we present the results obtained in an in vitro dissolution test and in vivo bioavailability study of some ketoconazol preparations (Ketoconazol – Traphaco, Vietnam and Nizoral – Janssen, Belgium). Rabbit plasma ketoconazol concentrations were measured by reverse phase HPLC, UV detection at 244 nm. Ketoconazol percentage released from the preparations was automatically measured using a paddle type dissolution tester with a Beckman spectrophotometer. The obtained results showed that there was no remarkable difference in bioavailability and dissolution between the two preparations (Ketoconazol – Traphaco and Nizoral - Janssen)
Ketoconazole
;
Imidazoles
;
tablets
;
Pharmaceutical Preparations
;
therapeutics
6.The Effect of Ketoconazole in the Treatment of Candida albicans Keratitis in Rabbits.
Journal of the Korean Ophthalmological Society 1988;29(4):529-533
Candida albicans keratitis was established in rabbits by intrastromal injection of a suspension containing 1.2 X 10(4) spores. After a 48-hour incubation period, the animals were treated with oral ketoconazole(10mg/kg daily) alone and in combination with topical ketoconazole(2% solution ten times a day) for 2 weeks. Clinical scores were significantly lower in both treated groups than in the control group. But there was no significant difference between the two treated groups.
Animals
;
Candida albicans*
;
Candida*
;
Keratitis*
;
Ketoconazole*
;
Rabbits*
;
Spores
7.The Safety of Antifungal Agents.
Korean Journal of Medical Mycology 2001;6(3):129-134
For the thirty years till 1990, griseofulvin and ketoconazole had been the only available oral antifungal agents. These drugs have not been used widely due to their many drawbacks such as low therapeutic efficacy, long duration of treatment and serious side effects. Nowadays, the newer oral antifungal agents, itraconazole, terbinafine, and fluconazole are used widely because of the improved therapeutic efficacy and an acceptable adverse effects profile. But, there is a spectrum of adverse effects and drug interactions for the these newer oral antifungal agents. In terms of the safety of these newer oral antifungal agents, I think that a little concerns of the dermatologists can reduce the possible adverse effects and the various drug interactions.
Antifungal Agents*
;
Drug Interactions
;
Fluconazole
;
Griseofulvin
;
Itraconazole
;
Ketoconazole
8.In Vitro antifungal Activities of Imidazole Derivatives.
Hong Sang CHIN ; Kwang Hoon LEE ; Chung Koo CHO
Korean Journal of Dermatology 1984;22(2):196-205
The present study was designed to obtain omparative data on in vitro antifungal activities of imidazole derivatives. Minimum inhibitory oncentrations of clotrimazole, miconazole, econazole, ketoconazlole and griseofulvin on 4 strains of Trichophyton mentagrophytes, 3 strains of Trichophyton rubrum, 2 strains of Microsporum canis and ] strain of Sporothriv: schenckii were etermined after 3 week' incubation at room temperature on Sabouraud's dextrose liquid media. In addition, the fungicidal activities of miconazole and econazole were tested against Z'richophyton mentagrophytes and Microsporum canis, using the techniques described by Vanbreuseghern(1967) The results are summarzed as follows: ] In most of the dermatophytes studied, 1 to 10 pg/ml of M1C were detected. Diverse susceptibility pattern was observed among different fungal species, but no or minor variability was noted within the same species. The susceptibility of Z'ri- chophyton rubrum showed at MIC of 0. 01 to 10 pg/ml, T ichophyton mentagro- phyt.es and Mic osporum canis at 0.1 to 10 pg/ml and 0. 1 to 1000 gg/ml respec- tively. The Trichophyton rubrum was the most sensitive. In the susceptibility test of Sporothrix schenckii, the high resistance to clotrimazole and griseofuhin was observed. The fungistatic activities of miconazole, econazole and ketoconazole were observed only at concentrations higher than JpQ pg/ml.
Arthrodermataceae
;
Clotrimazole
;
Econazole
;
Glucose
;
Griseofulvin
;
Ketoconazole
;
Miconazole
;
Microsporum
;
Sporothrix
;
Trichophyton
9.A Case of Cughing's Disease which Responded to the Combined Treatment of Ketoconazole and Octreotide.
Chan Soo SHIN ; Chang Hoon YIM ; Jae Jun KOH ; Sung Yeon KIM ; Bo Yeon CHO ; Hong Gyu LEE
Journal of Korean Society of Endocrinology 1998;13(1):94-98
The treatment of choice for Cushing's disease is surgical removal of tumor, the source of ACTH overproduction. In occasional patients in whom a surgical approach including total adrenalectomy is not feasible or surgical removal of tumor is not complete, medical treatment may be necessary because pituitary irradiation requires a long 1ag time to remission. Although ketoconazole, an imidazole derivative with inhibitory activity on adrenal steroidogenesis has been reported to be effective in the treatment of Cushing's disease, the limited effectiveness in lowering very high level of cortisol and occasional hepatotoxicity restrains its wide use. In this report, we describe a woman with Cushing's disease due to pituitary microadenoma. Transsphenoidal pituitary adenomeetomy followed by ketoconzole treatment had been unsuccessful in achieving remission of the disease, but combined treatment with ketoconazole and octreotide accomplished successful reduction in cortisol production.
Adrenalectomy
;
Adrenocorticotropic Hormone
;
Female
;
Humans
;
Hydrocortisone
;
Ketoconazole*
;
Octreotide*
;
Pituitary Irradiation
10.A Case of Neonatal Malassezia pustulosis induced by Malassezia sympodialis.
Ki Sung KIM ; Young Chul KYE ; Soo Nam KIM ; Kyu Joong AHN
Korean Journal of Dermatology 2000;38(10):1427-1429
A 2-month-old male patient visited with recurrent erythematous papules and pustules on face and neck that had developed 20 days after birth. Direct microscopic examination on smears for pustules showed forms of yeasts and culture yielded Malassezia sympodialis. Applying topical 2% ketoconazole cream for 15 days showed marked clinical improvement. We report this case of neonatal Malassezia pustulosis which be would probably improperly termed as neonatal acne with the review of literature.
Acne Vulgaris
;
Humans
;
Infant
;
Ketoconazole
;
Malassezia*
;
Male
;
Neck
;
Parturition
;
Yeasts